Optimisation of EGFR TKI efficiency wild-type EGFR lung cancer

被引：0
|
作者：
Raimbourg, Judith [1 ]
Cabart, Mathilde [1 ]
Joalland, Marie-Pierre [1 ]
Decaudin, Didier [2 ]
Deplater, Ludmilla [2 ]
Lanoe, Didier [1 ]
Douillard, Jean-Yves [1 ]
Bennouna, Jaafar [1 ]
Vallette, Francois [3 ]
Lalier, Lisenn [1 ]
机构：
[1] Inst Cancerol Ouest, St Herblain, France
[2] Inst Curie, Paris, France
[3] INSERM, Nantes, France
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2559
引用
收藏
页数：2
相关论文
共 50 条
  • [21] EGFR WILD-TYPE NSCLC PATIENTS WITH HIGH MIR-200C EXPRESSION CAN BENEFIT FROM EGFR-TKI
    Li, Jiayu
    Li, Xuefei
    Ren, Shengxiang
    Chen, Xiaoxia
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S133 - S133
  • [22] Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib
    Raimbourg, Judith
    Joalland, Marie-Pierre
    Cabart, Mathilde
    de Plater, Ludmilla
    Bouquet, Fanny
    Savina, Ariel
    Decaudin, Didier
    Bennouna, Jaafar
    Vallette, Francois M.
    Lalier, Lisenn
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1634 - 1644
  • [23] Significance of the estrogen signaling pathway in EGFR wild-type lung adenocarcinoma.
    Tanaka, Kazumi
    Shimizu, Kimihiro
    Nagashima, Toshiteru
    Ohtaki, Yoichi
    Kaira, Kyoichi
    Horiguchi, Jun
    Oyama, Tetsunari
    Takeyoshi, Izumi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
    Zheng, Hongmei
    Zhang, Yuting
    Zhan, Yuting
    Liu, Sile
    Lu, Junmi
    Feng, Juan
    Wu, Xia
    Wen, Qiuyuan
    Fan, Songqing
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6139 - 6150
  • [25] Marked Response to Icotinib in Lung Squamous Cell Carcinoma with EGFR Wild-Type
    Fan, Tao
    Zhou, Ju-Ying
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (06): : S120 - S122
  • [26] Biomarkers of lung cancer response to EGFR-TKI
    Johnson, B.
    EJC SUPPLEMENTS, 2007, 5 (08): : 14 - 15
  • [27] Biological and clinical significance of wild-type EGFR, EGFR ligands and putative cancer stem cell biomarkers in colorectal cancer
    Khelwatty, Said A.
    Essapen, Sharadah
    Bagwan, Izhar
    Seddon, Alan M.
    Modjtahedi, Helmout
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S19 - S19
  • [28] A study of EGFR wild-type non-small cell lung cancer ALK genetic mutation
    Wang, Shoufeng
    Mao, Naiquan
    Zuo, Chuantian
    Pan, Hong
    Xie, Tong
    Huang, Yaoyuan
    Pan, Qi
    Wu, Junwei
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 976 - 980
  • [29] Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses
    Anakura, Mai
    Nachankar, Ankita
    Kobayashi, Daijiro
    Amornwichet, Napapat
    Hirota, Yuka
    Shibata, Atsushi
    Oike, Takahiro
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (15)
  • [30] A meta-analysis of comparing EGFR-TKI with chemotherapy as the second-line treatment of NSCLC patients with wild-type EGFR.
    Gao, Guanghui
    Ren, Shengxiang
    Li, Aiwu
    He, Yayi
    Chen, Xiaoxia
    Li, Wei
    Zhou, Fei
    Li, Shuai
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345